168 related articles for article (PubMed ID: 19098003)
61. Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells.
Park YJ; Lee H; Lee JH
BMB Rep; 2010 Feb; 43(2):91-6. PubMed ID: 20193126
[TBL] [Abstract][Full Text] [Related]
62. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
Lee H; Akita RW; Sliwkowski MX; Maihle NJ
Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
[TBL] [Abstract][Full Text] [Related]
63. Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase.
Gesmundo I; Di Blasio L; Banfi D; Villanova T; Fanciulli A; Favaro E; Gamba G; Musuraca C; Rapa I; Volante M; Munegato S; Papotti M; Gontero P; Primo L; Ghigo E; Granata R
Cancer Lett; 2019 May; 449():252-262. PubMed ID: 30790678
[TBL] [Abstract][Full Text] [Related]
64. Expression of receptors for neuregulins, ErbB2, ErbB3 and ErbB4, in developing mouse cerebellum.
Ozaki M; Kishigami S; Yano R
Neurosci Res; 1998 Apr; 30(4):351-4. PubMed ID: 9678639
[TBL] [Abstract][Full Text] [Related]
65. SUMOylation regulates nuclear accumulation and signaling activity of the soluble intracellular domain of the ErbB4 receptor tyrosine kinase.
Knittle AM; Helkkula M; Johnson MS; Sundvall M; Elenius K
J Biol Chem; 2017 Dec; 292(48):19890-19904. PubMed ID: 28974580
[TBL] [Abstract][Full Text] [Related]
66. Mutational activation of ErbB2 reveals a new protein kinase autoinhibition mechanism.
Fan YX; Wong L; Ding J; Spiridonov NA; Johnson RC; Johnson GR
J Biol Chem; 2008 Jan; 283(3):1588-1596. PubMed ID: 18039657
[TBL] [Abstract][Full Text] [Related]
67. Somatic mutations of the ERBB4 kinase domain in human cancers.
Soung YH; Lee JW; Kim SY; Wang YP; Jo KH; Moon SW; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
Int J Cancer; 2006 Mar; 118(6):1426-9. PubMed ID: 16187281
[TBL] [Abstract][Full Text] [Related]
68. ErbB Receptors and Cancer.
Wang Z
Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
[TBL] [Abstract][Full Text] [Related]
69. ErbB4 activation inhibits MPP+-induced cell death in PC12-ErbB4 cells: involvement of PI3K and Erk signaling.
Di Segni A; Farin K; Pinkas-Kramarski R
J Mol Neurosci; 2006; 29(3):257-67. PubMed ID: 17085783
[TBL] [Abstract][Full Text] [Related]
70. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.
Muraoka-Cook RS; Sandahl M; Husted C; Hunter D; Miraglia L; Feng SM; Elenius K; Earp HS
Mol Biol Cell; 2006 Sep; 17(9):4118-29. PubMed ID: 16837552
[TBL] [Abstract][Full Text] [Related]
71. Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study.
Jabbarzadeh Kaboli P; Leong MP; Ismail P; Ling KH
Pharmacol Rep; 2019 Feb; 71(1):13-23. PubMed ID: 30343043
[TBL] [Abstract][Full Text] [Related]
72. Gab1 signaling is regulated by EGF receptor sorting in early endosomes.
Kostenko O; Tsacoumangos A; Crooks D; Kil SJ; Carlin C
Oncogene; 2006 Oct; 25(50):6604-17. PubMed ID: 16715136
[TBL] [Abstract][Full Text] [Related]
73. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
74. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
[TBL] [Abstract][Full Text] [Related]
75. H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent.
Carón RW; Yacoub A; Zhu X; Mitchell C; Han SI; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
Mol Cancer Ther; 2005 Feb; 4(2):243-55. PubMed ID: 15713896
[TBL] [Abstract][Full Text] [Related]
76. Alpha 2-Adrenergic Receptor Agonist Brimonidine Stimulates ERK1/2 and AKT Signaling via Transactivation of EGF Receptors in the Human MIO-M1 Müller Cell Line.
Harun-Or-Rashid M; Hallböök F
Curr Eye Res; 2019 Jan; 44(1):34-45. PubMed ID: 30198788
[TBL] [Abstract][Full Text] [Related]
77. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
78. Inhibition of platelet-derived growth factor receptor tyrosine kinase and downstream signaling pathways by Compound C.
Kwon HJ; Kim GE; Lee YT; Jeong MS; Kang I; Yang D; Yeo EJ
Cell Signal; 2013 Apr; 25(4):883-97. PubMed ID: 23277201
[TBL] [Abstract][Full Text] [Related]
79. Ligand-independent regulation of ErbB4 receptor phosphorylation by activated Ras.
Tal-Or P; Erlich S; Porat-Shliom N; Goldshmit Y; Ben-Baruch G; Shaharabani E; Kloog Y; Pinkas-Kramarski R
J Cell Biochem; 2006 Aug; 98(6):1482-94. PubMed ID: 16518842
[TBL] [Abstract][Full Text] [Related]
80. Expression of the ErbB4 receptor causes reversal regulation of PP2A in the Shc signal transduction pathway in human cancer cells.
Yumoto N; Yu X; Hatakeyama M
Mol Cell Biochem; 2006 Apr; 285(1-2):165-71. PubMed ID: 16477370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
